The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2021.1874917
Abstract: ABSTRACT Introduction: The safety of subcutaneous immunotherapy (SCIT), and particularly the dramatic issue of fatal reactions, has been an obstacle that limited the implementation of a therapy with unique characteristics of action on the causes… read more here.
Keywords: immunotherapy rare; sublingual immunotherapy; safety; safety sublingual ... See more keywords